Trial Profile
A phase I study of Valbenazine for the treatment of drug-induced dyskinesia
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 01 Aug 2016
Price :
$35
*
At a glance
- Drugs Valbenazine (Primary)
- Indications Drug-induced dyskinesia
- Focus Adverse reactions
- 01 Aug 2016 This study has been created from information based on company pipeline. (http://www.mt-pharma.co.jp/e/develop/pipeline/e_pipeline1603.pdf)
- 01 Aug 2016 New trial record